What is the first line treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Cellulitis

Cephalexin (500 mg orally 3-4 times daily for 5-6 days) is the first-line treatment for uncomplicated cellulitis targeting Streptococcus and methicillin-sensitive Staphylococcus aureus. 1

Treatment Algorithm for Cellulitis

Standard First-Line Therapy

  • Cephalexin: 500 mg orally 3-4 times daily for 5-6 days
    • Recommended by the American College of Emergency Physicians as the gold standard for uncomplicated cellulitis 1
    • Effective against the most common causative organisms: β-hemolytic Streptococcus and methicillin-sensitive Staphylococcus aureus 2
    • Associated with cure rates of 90% or higher in uncomplicated cases 1

Alternative First-Line Options (for Penicillin Allergy)

  • Non-Type I Penicillin Allergy:
    • Cefpodoxime, cefuroxime axetil, or cefdinir 1
  • Type I (Immediate) Penicillin Allergy:
    • Clindamycin: 300-450 mg orally three times daily for 5-6 days 1
    • Provides coverage against MRSA, streptococci, and anaerobes

Special Considerations

MRSA Risk Factors

If patient has risk factors for MRSA (prior MRSA infection, frequent hospitalizations, immunocompromised status, athletes, prisoners, etc.):

  • Add trimethoprim-sulfamethoxazole (1-2 DS tablets orally twice daily) or
  • Switch to clindamycin (300-450 mg orally three times daily) 1, 3

Severe Infections

For more severe infections requiring parenteral therapy:

  • Ceftriaxone: 50 mg/kg per day 1

Duration of Treatment

  • A 5-day course of antimicrobial therapy is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement occurs by day 5 1, 4
  • Most patients should show improvement within 48-72 hours of starting appropriate antibiotic therapy 1

Monitoring and Follow-up

  • If no improvement is seen after 72 hours:
    1. Reevaluate diagnosis
    2. Consider changing antibiotic therapy
    3. Evaluate for possible abscess formation requiring drainage 1

Important Clinical Pearls

Diagnostic Considerations

  • Cellulitis is a clinical diagnosis based primarily on history and physical examination 2
  • Look for acute onset of redness, warmth, swelling, tenderness, and pain 5
  • Be aware of conditions that mimic cellulitis (pseudocellulitis): venous stasis dermatitis, contact dermatitis, eczema, lymphedema 5

Common Pitfalls to Avoid

  1. Unnecessary MRSA coverage in areas with low MRSA prevalence 1

    • Even with rising rates of community-acquired MRSA, coverage for non-purulent cellulitis is generally not recommended 5
  2. Treating for too long when shorter courses are equally effective 1, 4

    • 5 days is sufficient for most uncomplicated cases 4
  3. Failing to distinguish between cellulitis and pseudocellulitis 1

  4. Not performing incision and drainage for abscesses 1

    • Antibiotics alone are insufficient for abscess treatment
  5. Failing to elevate the affected limb to reduce edema 1

  6. Not considering underlying predisposing factors that may lead to recurrence 1, 2

Special Populations

Pediatric Considerations

  • Cephalexin dosing: 25-50 mg/kg/day divided into 4 doses 1
  • Avoid doxycycline in children under 8 years due to risk of tooth discoloration 1

Pregnancy Considerations

  • Cephalexin is generally safe during pregnancy and breastfeeding 1
  • Doxycycline is contraindicated in pregnant women in the third trimester 1

By following this evidence-based approach to cellulitis treatment, clinicians can effectively manage most cases while minimizing complications and recurrence.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.